{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T17:56:58Z","timestamp":1770487018731,"version":"3.49.0"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1038\/nrneurol.2015.156","type":"journal-article","created":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T10:51:11Z","timestamp":1441104671000},"page":"552-553","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Stroke prevention\u2014time to say goodbye to the ABCD2 score?"],"prefix":"10.1038","volume":"11","author":[{"given":"Hans-Christoph","family":"Diener","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedikt","family":"Frank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,1]]},"reference":[{"key":"BFnrneurol2015156_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0140-6736(05)66702-5","volume":"366","author":"PM Rothwell","year":"2005","unstructured":"Rothwell, P. M.  et al. A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack. Lancet 366, 29\u201336 (2005).","journal-title":"Lancet"},{"key":"BFnrneurol2015156_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(07)60150-0","volume":"369","author":"SC Johnston","year":"2007","unstructured":"Johnston, S. C.  et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 369, 283\u2013292 (2007).","journal-title":"Lancet"},{"key":"BFnrneurol2015156_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1747-4949.2008.00182.x","volume":"3","author":"SB Coutts","year":"2008","unstructured":"Coutts, S. B.  et al. An improved scoring system for identifying patients at high early risk of stroke and functional impairment after an acute transient ischemic attack or minor stroke. Int. J. Stroke 3, 3\u201310 (2008).","journal-title":"Int. J. Stroke"},{"key":"BFnrneurol2015156_CR4","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1161\/STROKEAHA.109.562157","volume":"41","author":"C Weimar","year":"2010","unstructured":"Weimar, C.  et al. Prediction of recurrent stroke and vascular death in patients with transient ischemic attack or nondisabling stroke: a prospective comparison of validated prognostic scores. Stroke 41, 487\u2013493 (2010).","journal-title":"Stroke"},{"key":"BFnrneurol2015156_CR5","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1212\/WNL.0000000000001780","volume":"85","author":"JM Wardlaw","year":"2015","unstructured":"Wardlaw, J. M.  et al. ABCD2 score and secondary stroke prevention: meta-analysis and effect per 1,000 patients triaged. Neurology 85, 373\u2013380 (2015).","journal-title":"Neurology"},{"key":"BFnrneurol2015156_CR6","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1161\/STROKEAHA.108.192218","volume":"40","author":"JD Easton","year":"2009","unstructured":"Easton, J. D.  et al. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association\/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke 40, 2276\u20132293 (2009).","journal-title":"Stroke"},{"key":"BFnrneurol2015156_CR7","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/S1474-4422(07)70248-X","volume":"6","author":"PC Lavallee","year":"2007","unstructured":"Lavallee, P. C.  et al. A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurol. 6, 953\u2013960 (2007).","journal-title":"Lancet Neurol."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2015.156.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2015.156","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2015.156.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:16:06Z","timestamp":1684469766000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2015.156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,1]]},"references-count":7,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["BFnrneurol2015156"],"URL":"https:\/\/doi.org\/10.1038\/nrneurol.2015.156","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,1]]},"assertion":[{"value":"1 September 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.-C.D. has received honoraria for participation in clinical trials, contribution to advisory boards or oral presentations from: Abbott, Allergan, AstraZeneca, Bayer Vital, BMS, Boehringer Ingelheim, CoAxia, Corimmun, Covidien, Daiichi-Sankyo, D-Pharm, Fresenius, GlaxoSmithKline, Janssen-Cilag, Johnson & Johnson, Knoll, Lilly, MSD, Medtronic, MindFrame, Neurobiological Technologies, Novartis, Novo-Nordisk, Paion, Parke-Davis, Pfizer, Sanofi-Aventis, Schering-Plough, Servier, Solvay, St. Jude, Syngis, Talecris, Thrombogenics, WebMD Global, Wyeth and Yamanouchi. Financial support for his research projects was provided by AstraZeneca, GlaxoSmithKline, Boehringer Ingelheim, Lundbeck, Novartis, Janssen-Cilag, Sanofi-Aventis, Syngis and Talecris. He has no ownership interest and does not own stocks in any pharmaceutical company. Within the past year, H.-C.D. has served as an editor for Aktuelle Neurologie, Arzneimitteltherapie, Kopfschmerznews, Stroke News and the Treatment Guidelines of the German Neurological Society, as co-editor of Cephalalgia, and on the editorial boards of The Lancet Neurology, Stroke, European Neurology and Cerebrovascular Disorders. B.F. has received honoraria from Sanofi and Bayer HealthCare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}